US SEC moves toward requiring more reporting on climate change March 21, 2022 By Mari Serebrov No Comments If the U.S. SEC adopts a rule it proposed March 21, all public companies registered with the regulator, including biopharma and med-tech firms, will have to add disclosures about climate change to their other reporting obligations.Read More
Academics failing when it comes to reporting EU trial results July 5, 2019 By Mari Serebrov No Comments Academic sponsors of clinical trials in the EU are the worst offenders when it comes to not posting completed trial results in the EudraCT database.Read More